Related Experiment Video

Updated: Nov 23, 2025

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
14:32

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Published on: February 27, 2016

8.5K

The relationship between coronary artery disease and SIRT1 protein

Lutfu Askin1, Hakan Tibilli1, Okan Tanriverdi1

  • 1Department of Cardiology, Adiyaman Training and Research Hospital, Adiyaman, Turkey.

Northern Clinics of Istanbul
|December 31, 2020
PubMed

Insights

Sirtuin 1 (SIRT1) protein protects against endothelial dysfunction and vessel injury in coronary artery disease (CAD). Suppressing SIRT1 increases inflammation and monocyte adhesion, highlighting its therapeutic potential.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Biochemistry

Background:

  • Endothelial cell dysfunction, inflammation, and monocyte increase are key drivers of coronary artery disease (CAD) vessel injury.
  • Sirtuin 1 (SIRT1) protein is crucial for regulating cellular functions, including angiogenesis and protection against ischemia-reperfusion injury.
  • SIRT1 suppression exacerbates endothelial dysfunction by promoting monocyte adhesion.

Purpose of the Study:

  • To review the current understanding of sirtuin protein roles in CAD.
  • To explore the therapeutic potential of sirtuin activators in cardiovascular pathologies.
  • To outline future research directions for sirtuins in CAD treatment.

Main Methods:

  • Literature review of studies on SIRT1 and CAD.
  • Analysis of molecular mechanisms linking SIRT1 to endothelial function.
  • Synthesis of data on sirtuin activators in disease models.

Main Results:

  • SIRT1 plays a protective role in preventing endothelial dysfunction and vascular inflammation.
  • Reduced SIRT1 levels correlate with increased monocyte-endothelial cell interactions.
  • Sirtuin activators show promise for treating diseases involving endothelial dysfunction.

Conclusions:

  • SIRT1 is a critical regulator of vascular health in CAD.
  • Targeting SIRT1 pathways offers a promising therapeutic strategy for CAD.
  • Further research into sirtuin modulation is warranted for novel CAD treatments.

Keywords:
Coronary artery diseaseSirtuin 1endothelial cell dysfunctioninflammation

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.6K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
674
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
196
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
477
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
128
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
167
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
412